Back to 
CITADEL ADVISORS LLC
CITADEL ADVISORS LLC
AR2Showing 0 of 4 quarters
Position history for CITADEL ADVISORS LLC's holdings in ARRAY BIOPHARMA INC
As of its Q2 2019 13F, Citadel Advisors held 4,346,050 shares of AR2 (Array Biopharma), worth $201.4M. Citadel Advisors' 13F filings listed AR2 from Q4 2018 to Q2 2019, 3 quarterly filings. AR2 was 0.1% of Citadel Advisors' reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of AR2: FARALLON CAPITAL MANAGEMENT, L.L.C., HBK INVESTMENTS L P, Magnetar Financial LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC